Activating Compound | Comment | Organism | Structure |
---|---|---|---|
CpG oligodeoxynucleotides | induce PLD activation, increase PLD activity, PLD-dependent reactive oxygen intermediate production, PLD-dependent phagolysosome maturation, and PLD-dependent intracellular mycobacterial killing in type II alveolar epithelial cells | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
ethanol | - |
Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
A-549 cell | native or infected with Mycobacterium tuberculosis strain H73Rv, that is localized in endosomes at immature stage, CpG oligodeoxynucleotides treatment promotes maturation to mature phagolysosomes | Homo sapiens | - |
alveolar cell type II | - |
Homo sapiens | - |
Synonyms | Comment | Organism |
---|---|---|
PLD | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | PLD activity is a key enzyme involved in CpG oligodeoxynucleotides-induced intracellular mycobacterial killing in human monocytes/macrophages. Phagolysosome biogenesis from endosomes appears to be mediated by PLD activation, which is inhibited by ethanol in vivo in A-549 cells, overview | Homo sapiens |